RFK Jr. has pressured the FDA to reconsider its 2023 ban on 12 unproven peptides, scheduling advisory meetings without new safety data. These peptides are popular in wellness circles but lack scientific evidence for claimed benefits like anti-aging. The move reflects political influence over regulatory science.
Background
Peptides are short chains of amino acids used in proven drugs like insulin, but unproven versions are marketed online for anti-aging and wellness without FDA approval. The FDA banned 12 such peptides in 2023 due to safety concerns.
- Source
- Ars Technica
- Published
- Apr 17, 2026 at 12:45 AM
- Score
- 6.0 / 10